![Seong-Cheol Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seong-Cheol Park
Director/Board Member at
Curiox Biosystems, Inc.
Net worth: 499 322 $ as of 2026-06-29
Profile
Seong-Cheol Park is currently Director at Curiox Biosystems Pte Ltd. and Curiox BioSystems, Inc. Formerly, Director at Curiox Biosystems Co., Ltd. Educated at Korea Advanced Institute of Science & Technology with undergraduate and graduate degrees.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-15 | 16,000 ( 0.09% ) | 499 322 $ | 2026-06-29 |
Seong-Cheol Park active positions
| Companies | Position | Start |
|---|---|---|
Curiox Biosystems, Inc.
 Curiox Biosystems, Inc. Medical SpecialtiesHealth Technology Curiox Biosystems is a company that specializes in developing innovative technologies for life science research, diagnostics, and therapeutics discovery and development. The company was spun out of the Agency for Science, Technology, and Research (A*Star) and brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation. Curiox Biosystems' focus is on developing technologies that improve productivity and data quality by focusing on common assay steps where miniaturization and automation are currently underutilized. The aim is to simplify sample preparation while improving data quality and workflow, and to accelerate high-throughput flow and mass cytometry workflows with fully automated sample preparation. The Laminar Wash technology systems delivered by Curiox Biosystems are faster and easily automated, delivering higher quality data through better cell retention, improved preservation of cellular physiology and viability, exceptional study-to-study and operator-to-operator reproducibility. The company is based in Woburn, MA. The company was founded in 2008. The CEO is Namyong Kim. | Director/Board Member | - |
Curiox Biosystems Pte Ltd.
 Curiox Biosystems Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Develops innovative assay platforms | Director/Board Member | - |
Former positions of Seong-Cheol Park
| Companies | Position | End |
|---|---|---|
| CURIOX BIOSYSTEMS CO., LTD | Director/Board Member | - |
Training of Seong-Cheol Park
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Korea Advanced Institute of Science & Technology
 Korea Advanced Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Curiox Biosystems Pte Ltd.
Curiox Biosystems Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Develops innovative assay platforms | Commercial Services |
Curiox Biosystems, Inc.
Curiox Biosystems, Inc. Medical SpecialtiesHealth Technology Curiox Biosystems is a company that specializes in developing innovative technologies for life science research, diagnostics, and therapeutics discovery and development. The company was spun out of the Agency for Science, Technology, and Research (A*Star) and brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation. Curiox Biosystems' focus is on developing technologies that improve productivity and data quality by focusing on common assay steps where miniaturization and automation are currently underutilized. The aim is to simplify sample preparation while improving data quality and workflow, and to accelerate high-throughput flow and mass cytometry workflows with fully automated sample preparation. The Laminar Wash technology systems delivered by Curiox Biosystems are faster and easily automated, delivering higher quality data through better cell retention, improved preservation of cellular physiology and viability, exceptional study-to-study and operator-to-operator reproducibility. The company is based in Woburn, MA. The company was founded in 2008. The CEO is Namyong Kim. | Health Technology |
Curiox Biosystems Co., Ltd.
 Curiox Biosystems Co., Ltd. Packaged SoftwareTechnology Services Develops bio equipment technology company | Technology Services |
- Stock Market
- Insiders
- Seong-Cheol Park
